In Brief
The neutrophil differentiation pathway is poorly defined. Evrard et. al. demonstrate a workflow of characterizing bone marrow neutrophil subsets on the basis of their proliferative capacity and molecular signatures and thereby define the developmental trajectory and functional properties of neutrophils.
SUMMARY
Neutrophils are specialized innate cells that require constant replenishment from proliferative bone marrow (BM) precursors as a result of their short half-life. Although it is established that neutrophils are derived from the granulocyte-macrophage progenitor (GMP), the differentiation pathways from GMP to functional mature neutrophils are poorly defined. Using mass cytometry (CyTOF) and cellcycle-based analysis, we identified three neutrophil subsets within the BM: a committed proliferative neutrophil precursor (preNeu) which differentiates into non-proliferating immature neutrophils and mature neutrophils. Transcriptomic profiling and functional analysis revealed that preNeu require the C/EBPε transcription factor for their generation from the GMP, and their proliferative program is substituted by a gain of migratory and effector function as they mature. preNeus expand under microbial and tumoral stress, and immature neutrophils are recruited to the periphery of tumor-bearing mice. In summary, our study identifies specialized BM granulocytic populations that ensure supply under homeostasis and stress responses.
INTRODUCTION
Neutrophils are the most abundant immune cell type in human peripheral blood and act as the first responders during sterile and microbial insults. They elicit powerful effector functions to eliminate foreign threats and play crucial roles in tissue remodeling (Borregaard, 2010; Kolaczkowska and Kubes, 2013) . Neutrophils are short lived; they have an estimated half-life of 19 hr in humans (Lahoz-Beneytez et al., 2016; Tak et al., 2013) . Therefore, neutrophils must be constantly replenished; an impairment in their production and migration leads to neutropenia and lifethreatening conditions (Summers et al., 2010) .
Historically, neutrophil development has been defined by histological staining and electron microscopy into stages based on neutrophil size, nucleus morphology, and cytosol coloration. After maturation, neutrophils are retained in the BM through CXCR4 chemokine receptor signaling, and CXCR2 signaling drives their release into the circulation (Devi et al., 2013) . During inflammation, increased amounts of granulocyte-colony-stimulating factor (G-CSF) can potentiate mobilization of neutrophils from the BM by lowering the threshold of their release (Kim et al., 2006) and increasing the amounts of mobilizing signals (i.e., CXCL1) (Kö hler et al., 2011) .
It is believed that neutrophils consist of a homogeneous population. However, this view is rapidly evolving thanks to increasing reports of neutrophil heterogeneity (reviewed in (Silvestre-Roig et al., 2016)). Notably, these studies focused (legend continued on next page) primarily on the phenotype of circulating neutrophils but not their ontogeny. Therefore, the functional heterogeneous populations at the early maturation stages remain undefined. Myeloid cell development begins with the common myeloid progenitor (CMP), which gives rise to the granulocyte-monocyte progenitor (GMP) (Akashi et al., 2000) . GMPs have also been shown to give rise to the common DC progenitor (CDP) and common monocyte progenitor (cMoP) that only form DCs or monocytes, respectively (Hettinger et al., 2013; Naik et al., 2007) . However, the developmental trajectory from GMP to functionally mature neutrophils remains poorly defined. To address this, we utilized multiparameter analytical techniques to investigate the differentiation pathways and functional properties of neutrophil subsets in steady and inflammatory states.
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RESULTS
Multiparameter Analysis of Bone Marrow Cells Identifies Proliferating Neutrophils with Distinct Phenotypic Signatures
Cellular proliferation is central to hematopoiesis. The classical model suggests a hierarchical order, which begins when the cellular amplification of hematopoietic stem cells (HSCs) leads to the generation of all blood cell lineages ( Figure 1A ) (Manz and Boettcher, 2014; Orkin and Zon, 2008) . Upon differentiation of slow proliferating HSCs to hematopoietic progenitor cells (HPCs), HPCs commit toward their respective cell lineages by reducing their self-renewal capacity and proliferate extensively to meet the demand of mature lineage-specific cells (Figure 1A) . HPC differentiation to mature leukocytes represents a late stage of development for most immune cells, and thus, with the exception of lymphocytes, DCs, and tissue-resident macrophages, mature leukocytes have little ability to self-renew or proliferate ( Figure 1A ) (Ginhoux and Jung, 2014; Manz and Boettcher, 2014) . To determine whether this hematopoietic proliferative framework can be delineated experimentally, we analyzed various immune cell types at different stages of development by using the Fucci-474 reporter mouse that labels cells undergoing the S, G2, or M phase of the cell cycle [termed Fucci-(S-G2-M)] (Sakaue- Tomura et al., 2013) . We found that less than 10% of HSCs and mature leukocytes were in the cell cycle ( Figure 1B ). In contrast, more than 40% of GMPs engaged in cell proliferative activity ( Figure 1B ), in agreement with previously published data (Yo et al., 2015) .
To explore the phenotypic diversity between cycling leukocytes and those in cell-cycle arrest, we utilized mass cytometry to segregate major leukocyte lineages in the BM (Becher et al., 2014) through 40 different expression markers. CD45 + hematopoietic cells were first separated into proliferative IdU + and non-proliferative IdU À cells ( Figure 1C ). We next utilized the t-distributed stochastic neighbor embedding (t-SNE) algorithm to visualize similarities between cells on a 2D map ( Figure 1C) and used Cytofkit to generate clusters van der Maaten and Hinton, 2008) . Using this method, we confirmed that HPCs such as CMPs and GMPs were highly proliferative and were present only among IdU + cells. In addition, mature and terminally differentiated leukocytes were only present within the IdU À populations.
Notably, neutrophils formed the second largest cluster in both the proliferating and non-proliferating subsets ( Figure 1C, green) . However, although B cell precursors, which form the largest cluster among proliferative cells, are well defined, the identification of a neutrophil committed precursor and its subsequent developmental stages remains unclear. Hence, we extracted the median intensities of each marker and generated heat maps for every identified cluster among the proliferating and non-proliferating populations ( Figure 1D ). We next explored differentially expressed markers among neutrophils by performing a side-by-side comparison of the markers expressed between IdU + and IdU À neutrophils ( Figure 1E ). Using this approach, we found differentially expressed markers between proliferative and non-proliferative neutrophils; such markers included cKit, CXCR2, Ly6G, Gr1, CD62L and CXCR4. Of note, this approach not only was valid for neutrophils but also was able to identify markers expressed differentially in IdU + and IdU À basophils, eosinophils and Ly6C hi monocytes ( Figure S1 ).
Collectively, our approach redefines the identity of neutrophil precursors by categorizing their maturation stages according to their proliferative and molecular properties.
Fucci-(S-G2-M) Reporter Mouse Reveals a Proliferative Neutrophil Precursor
To identify a committed neutrophil progenitor or precursor, we used the markers identified in Figure 1E Figure 2A ). Dimensional reduction with t-SNE revealed two distinct clusters that were distinguishable on the basis of Fucci-(S-G2-M) expression ( Figure 2B ). We next compared the expression of various markers between proliferating
] neutrophils. In agreement with the mass-cytometry data ( Figure 1E ), non-proliferating neutrophils highly expressed Ly6G and CXCR2, whereas proliferating neutrophils were Ly6G lo CXCR2 À and were positive for cKit and CXCR4 ( Figure 2C ). This ''Fuccibased'' approach proved to be robust in that it identified proliferative transitional pre-monocytes (tpMo) among BM Ly6C hi monocytes ( Figure S2 ), which we have recently characterized . Taken together, our cell-cycle-based approaches have identified heterogeneity among the neutrophil lineage and revealed a putative proliferative neutrophil precursor, which we term preneutrophils (preNeus).
(D) On the basis of the clusters identified in (C), median intensities for each marker were calculated and plotted as heat maps so taht the respective immune cell populations could be identified. (E) A heat map of surface-marker expression (median intensity) for IdU + and IdU À neutrophils shows differentially expressed markers (black arrows).
(C-E) Data are representative of one out of two independent experiments (n = 3) (see also Figure S1 ).
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CD115,Siglec-F CD11b PreNeus Form Clusters in Close Proximity to CXCL12-Abundant Reticular (CAR) Cells Hematopoietic lineage survival and development requires specialized BM niche factors to generate mature hematopoietic cells from HSCs and HPCs (Frenette et al., 2013) . Because preNeu display proliferative activity ( Figures 2B and 2C) , we next investigated whether they were localized in a specialized niche.
Magnified femur areas ( Figure 2D ) revealed that S100A9 + Fucci-(S-G2-M) + preNeus were preferentially found in clusters in vivo, consistent with their proliferative activity ( Figure 2D ). Furthermore, preNeus were situated closely to CXCL12 chemokine-expressing cells ( Figure 2E ) showed an approximate 2-fold increase in BM preNeus as compared to wild-type counterparts ( Figure 2G ).
In summary, our data indicate that proliferating preNeus cluster in close proximity to CAR cells and are retained in the BM through CXCR4.
Neutrophils Express Distinct Genetic Signatures throughout Their Development
Although our cell-cycle-based approaches have identified proliferative preNeus, it remains unclear how they might fit within the neutrophil lineage. To address this question, we analyzed the Lin -
Gr1
+ CD11b + neutrophil fraction and excluded cKit + CXCR4 + preNeus ( Figure 3A and Figure S3A ). Although blood neutrophils were mostly Ly6G + and CXCR2 + , BM neutrophils were heterogeneous for these two markers, such that they segregated into Ly6G + CXCR2 + neutrophils that resemble blood neutrophils and a population of Ly6G lo/+ CXCR2 À neutrophils that appeared to be immature on the basis of the lack of CXCR2 ( Figure 3A ). To better understand the developmental relationship between preNeus, immature neutrophils (Ly6G lo/+ CXCR2 À ; termed immature Neus) and mature neutrophils (Ly6G + CXCR2 + ; termed mature Neus), we sorted these three subsets and compared their morphology with sorted GMPs and blood neutrophils. Although GMP displayed a largely uncondensed nucleus with an immature cytosol, neutrophils progressively condensed their nucleus from a toroidal shape in preNeus to a poly-segmented shape in BM mature and blood neutrophils ( Figure 3B ). We also identified preNeus and immature Neus in the spleen ( Figures S3B and  S3E ), but in much fewer numbers than in the BM (Figures S3C and S3D) , and these cells were absent from the blood (data not shown).
We next used whole-transcriptome sequencing (RNA-seq) to determine how the molecular signatures of these neutrophil precursors differed. Principal-component analysis (PCA) of all transcripts revealed distinct gene expression profiles between all subsets ( Figure 3C ). Furthermore, although GMPs, preNeus, and immature Neus displayed distinct gene signatures, the Pearson correlation matrix showed that BM mature Neus and blood Neus displayed a similar gene expression profile (Figure 3D ). Although BM immature Neus and mature Neus were distinguishable only through CXCR2 expression on the basis of our limited phenotypical analysis, these two subsets showed vast transcriptomic differences and had more than 3,000 differentially expressed genes ( Figure 3D and Figure S3F ).
We next plotted the 20% most variable genes in a heat map and identified seven distinct clusters of genes that were differentially regulated during neutrophil development ( Figure 3E ). Two gene clusters (1 and 2) were upregulated during neutrophil development and comprised genes involved in chemotaxis, neutrophil motility (cluster 1), and response to microbial stimuli (cluster 2) ( Figures 3F and 3G ). In contrast, two gene clusters (5 and 6) were downregulated during neutrophil development and consisted of genes involved in the cell cycle and regulation of gene expression ( Figures 3F and 3G ). Because our RNA-seq analysis revealed a progressive decrease in the expression of cell-cycle-associated genes during neutrophil development, we next determined the precise point where they lost their proliferative capacity in their lineage development. Using a dual Fucci reporting system 474 (S-G2-M)/639 (G0-G1) (Tomura expressed as an n-fold change in cell numbers ± SD (n = 10 mice per group). **p < 0.01; ****p < 0.0001 (see also Figure S2 ). (legend on next page) et al., 2013), we found that preNeus showed the highest number of cells in the S phase, whereas immature Neus abruptly arrested the cell cycle and progressively entered the G0 phase upon maturation into mature Neus ( Figure 3H and Figure S3H ). In agreement with these results, we found a downregulation of cell-cycle-related genes, including Mki67, Cdk1, and Top2a, as cells progressed from GMPs to mature Neus ( Figure S3G ). Having established that these neutrophil subsets are engaged in different stages of the cell cycle, we investigated how these differences could translate to biological function. To address this question, we performed in vitro culture of preNeus, immature Neus, and mature Neus for 2 days. Although the numbers of immature and mature neutrophils rapidly declined in culture, we found that preNeus could expand in culture (Figures 3H and 3I) . Colony-forming assays also revealed that, unlike GMPs, preNeus divided but did not form colonies, whereas immature and mature neutrophils did not divide at all (Figure S3J) . Altogether, we have characterized three discrete subsets of BM neutrophils that are phenotypically, morphologically, and transcriptionally distinct.
PreNeus Are Committed to the Neutrophil Lineage Although our current results suggested a maturation process from preNeus into immature Neus and then mature Neus, it remained unclear whether preNeus were fully committed to the neutrophil lineage. To address this question, we first compared the transcriptomic signature of members of the neutrophil and monocyte lineages with GMPs ( Figure 4A ). PCA of all transcripts revealed that preNeus were more similar to members of the neutrophil lineage, such as immature Neus, than they were to members of the monocyte lineage ( Figure 4A ).
To further understand the developmental continuum of neutrophil subsets, we used gene expression data from these subpopulations and performed a hierarchical clustering by optimal leaf ordering (OLO). A dendrogram obtained through this method determined a development order from GMP to preNeu, immature Neu, mature Neu, and finally blood neutrophil ( Figure S4A ).
We validated this result by devising a Cre-based fate-mapping strategy to follow the development of preNeus and their progeny. We based our strategy on the expression of S100a8 because we found this gene to be selectively upregulated only from the preNeu stage but minimally expressed in GMPs and cells from the monocyte lineage, consistent with previously published data ( Figure 4B and Figure S4B ) (Passegué et al., 2004; Reber et al., 2017) . We crossed S100a8 cre mice together with Rosa26
LsL-YFP mice and determined the recombination rate during the development of myeloid cells. Although GMPs showed no detectable recombination, preNeus exhibited an $40% recombination rate that progressively increased in immature, mature, and blood neutrophils to reach $80% recombination ( Figure 4C ). Similar results were found with a Lyz2 cre -based strategy ( Figures S4C and S4D ). In contrast, other myeloid cells, such as monocytes and eosinophils, showed <10% recombination rates ( Figure 4C ). Together, these results suggest that preNeus only give rise to immature and mature neutrophils. We next validated these results in vivo by transferring GFP + preNeus into the BM of wild-type recipients. These GFP + preNeus gave rise to immature Neus after one day and differentiated into mature Neus one day later ( Figure 4D ). Importantly, preNeus did not give rise to monocytes, eosinophils or other cell lineages, which further confirms our fate-mapping analyses ( Figure 4D ). To further establish the developmental timeline of preNeus in vivo, we exploited their intrinsic proliferative capacity as a marker ( Figure 3H and Figure S3H ). We employed 5-bromo-2 0 -deoxyuridine (BrdU) that is only incorporated into actively dividing cells such as preNeus, thereby allowing us to follow their differentiation over time as previously used for monocytes (Yona et al., 2013) . As expected, only preNeus were BrdU + 2h after administration ( Figure 4E ). Using this method, we found that preNeus progressively differentiated into immature Neus after 24 hr and mature Neus after 48 hr, and they finally egressed into the circulation after 72 hr ( Figure 4E ). In addition, treatment with the chemotherapeutic drug 5-fluorouracil (5-FU), which inhibits thymidine synthesis and causes dividing cells to undergo apoptosis, triggered a successive loss of GMPs, preNeus, and immature and mature Neus ( Figure 4F ).
Furthermore, we confirmed the presence of preNeus in humans by employing a workflow similar to that performed in Fig + total neutrophils and identified markers that were differentially expressed in proliferative (IdU + ) and non-proliferative (IdU À ) neutrophils; these markers included CD10, CD16, CD49d, and CD101 (Figures S4F and S4G) . Using this strategy, we identified the human equivalents of preNeus, immature Neus, and mature Neus ( Figures  S4H-S4K ). Akin to findings in mice, preNeus and immature Neus were virtually absent from the blood, thereby validating our workflow ( Figure S4J ). Figure S3H ). (I) Analysis of the in vitro proliferation assay of neutrophil subsets. Data are expressed as an n-fold-change in numbers ± SD (n = 3) and are representative of four independent experiments. ****p < 0.0001 (one-way ANOVA) (see also Figure S3 ). Together, our results provide evidence that preNeu acts as a proliferative precursor of the neutrophil lineage in both mice and humans.
The Development of preNeu to Mature Neu Is Accompanied by Functional Changes Associated with Maturation Thus far, our data suggested a developmental process whereby a preNeu becomes an immature Neu and finally a mature Neu. To gain further insights into the functional processes that occur during this maturation, we analyzed the gene expression of transcription factors (TFs) involved at different stages of myeloid cell development ( Figure 5A ). As anticipated, multipotent GMPs highly expressed Cebpa, which is necessary for granulopoiesis initiation, as well as TFs involved in the development of other myeloid lineages, such as Irf8, Gata1, and Gata2 (Fiedler and Brunner, 2012; Yá ñ ez et al., 2015) . In contrast, preNeus highly expressed Gfi1 and Cebpe, two TFs crucial for early neutrophil differentiation (Hock et al., 2003; Yamanaka et al., 1997) . Finally, mature and circulating neutrophils showed high expression of Cebpd and Spi1 (PU.1), which is in line with their role in terminal granulopoiesis (Borregaard, 2010) (Figure 5A ).
TFs from the C/EBP family promote the expression of granuleassociated enzymes. Specifically, C/EBPa induces the expression of primary granule enzymes (such as Mpo) (Ford et al., 1996) , whereas C/EBPε and C/EBPd promote secondary (such as Ltf) and tertiary granule enzymes (such as Mmp8), respectively (Gombart et al., 2003) . Because we observed a highlycoordinated expression of these TFs across the neutrophil lineage ( Figure 5A ), we next determined whether this pattern was correlated with granule expression. Indeed, whereas primary granules were mainly expressed at the GMP stage, secondary granules were formed mostly within preNeus and immature Neus, and tertiary granules were associated with mature Neus, thereby matching the expression patterns of C/EBPa, C/EBPε, and C/EBPd ( Figures 5A and 5B) .
We next determined the functional differences that occur across the different stages of differentiation. Hence, we looked at key genes involved in reactive oxygen species (ROS) production, phagocytosis and chemotaxis ( Figures 5C, 5F , and 5G). We found the highest expression of these genes among mature Neus ( Figures 5C, 5F , and 5G). This was associated with a superior capacity of mature Neus to produce ROS upon phorbol myristate acetate (PMA) stimulation (Figure 5D ) and to phagocytose bacteria ( Figure 5E ). In addition, we found that preNeus had a reduced migratory capacity; mature Neus quickly swarmed toward the necrotic core, whereas preNeus were immotile in response to sterile injury ( Figure 5H and Video S1).
Altogether, we found a progressive functional maturation of the neutrophil lineage during development such that mature Neus possessed the full range of neutrophil effector functions. C/EBPε Deficiency Impairs the Development of preNeus and Downstream Neutrophil Populations C/EBPε is a crucial TF for the production of secondary granules in mice and humans (Gombart et al., 2003; Yamanaka et al., 1997) . However, the precise involvement of C/EBPε in neutrophil development remains unclear. Because we had detected a strong upregulation of Cebpe expression in the preNeu population ( Figure 5A ), we hypothesized that C/EBPε could be involved in the transition from GMPs to preNeus. To examine this, we compared GMP, preNeu, immature Neu, and mature Neu numbers in the BM of Cebpe À/À and WT animals ( Figure 6A ).
We observed that preNeus and downstream populations were severely reduced but GMPs accumulated in Cebpe À/À mice, supporting the conclusion that Cebpe is important for the transition from GMPs to preNeus ( Figure 6A ). In contrast, we found an increase in tpMo and Ly6C hi monocyte numbers in Cebpe À/À mice ( Figure 6B ), which could indicate an aberrant differentiation of GMP to the monocyte fate. To confirm the role of C/EBPε in neutrophil development in a competitive setting, we generated BM chimeras with an equal mixture of CD45.1 + WT and Figure 6C ). In line with earlier results ( Figure 6A ), preNeus and downstream neutrophil populations were not derived from Cebpe À/À cells but from WT cells.
Because the development of preNeus is highly impacted in C/EBPε-deficient animals, we next investigated how a lack of preNeus during inflammatory responses would result in functional consequences. We utilized a neutrophil-dependent model of immune complex-mediated inflammation (reverse passive Arthus [RPA] reaction) (Li et al., 2016) . Here, we observed reduced neutrophil infiltration ( Figure 6D ) and vascular leakage ( Figure 6E ) at the site of the reaction. A mid-grade cecal ligation and puncture (CLP) sepsis model also revealed that Cebpe À/À mice had poorer bacterial clearance in the blood and peritoneal cavity than did wild-type control mice ( Figures 6F and 6G) . Together, these data indicate that the absence of preNeus in Cebpe À/À mice results in impaired development of downstream neutrophil populations.
PreNeus Expand in the Bone Marrow and the Spleen during Inflammation
Our data ( Figure 6 ) indicated that the absence of preNeus results in a lack of neutrophil-mediated responses. Because preNeus acted as proliferative precursors in the steady state, we next sought to understand how preNeus were affected during diseases such as sepsis and cancer, which require increased myelopoiesis. Specifically, we found an increase in preNeu numbers in the BM and spleen upon sepsis (Figures 7A and 7B and Figure S5A) . Additionally, we observed a similar effect in an orthotopic tumor model of pancreatic carcinoma ( Figures 7C and 7D and Figure S5B ). Of note, although we detected a 2-to 4-fold increase in BM preNeu numbers in both of these models, we noticed a significant and drastic >10-fold increase in spleen preNeu numbers ( Figures 7B and 7D ). Taken together, our Tumor Progression Neutrophils are being increasingly recognized as important players in tumorigenesis. However, conflicting evidence indicates that neutrophils can carry both pro-and anti-tumoral properties (Coffelt et al., 2016; Nicolá s-Á vila et al., 2017) . We speculated that these opposing observations might be explained by the differing maturation status of neutrophils in tumors, as others have recently suggested (Coffelt et al., 2016) . To address our hypothesis, we investigated whether immature and mature Neus might be identified in orthotopic pancreatic tumors via CXCR2 expression given that this marker is differentially expressed between these two populations in the BM ( Figure 3A) . However, unlike in the BM and blood, we found a strong downregulation of CXCR2 in the tumor ( Figure 7E ).
To overcome the challenge of segregating immature and mature Neus in the tumor, we screened for differentially expressed genes (DEGs) to identify markers that could clearly distinguish these cells in the tumor. Among these DEGs, we identified Cd101, which encodes a surface marker and was significantly upregulated in BM mature and blood Neus ( Figure 7F Figure 7G ).
Notably, CD101
À immature Neus were nearly absent from the circulation at baseline conditions ( Figure 7G ). Using CD101 to distinguish immature Neus, we first determined whether this approach would allow us to detect them in the circulation. We administered G-CSF, a strong neutrophil mobilizer that is similarly upregulated during cancer (Kowanetz et al., 2010) , to mice. Using this stimulus, we detected immature Neus in the blood, and their numbers were maintained in the circulation for up to 4 days after treatment ( Figures S5C and S5D ). Because immature Neus are able to enter the circulation, we next addressed whether these cells had the capacity to migrate into tissues. Both immature and mature Neus could swarm equally toward the injury core in a sterile laser injury model ( Figure S5E and Video S2). This is in sharp contrast to preNeus, which displayed poor interstitial motility ( Figure 5H and Video S1), and suggests that immature Neus already possess functional migratory machinery.
Having established that CD101 segregates immature Neus from mature Neus during G-CSF stimulation, we next validated this strategy in the tumor setting. Compared to naive mice, mice bearing pancreatic tumors showed increased numbers of immature Neus in the blood and pancreas (Figures 7H and 7I) . Furthermore, a positive correlation between the number of immature Neus in the blood and the number in the pancreas suggested that these cells were actively recruited to the tumor site from the circulation ( Figure 7J ). To test whether infiltration of immature Neus contributed to tumor progression, we separated tumor-bearing mice into two groups according to their tumor weight and found that mice with a higher tumor burden showed higher infiltration of immature Neus into the pancreas (Figures 7K-7M) . Additionally, mice with a higher tumor burden had significantly more immature Neus, but no significant differences in mature Neus in the circulation ( Figure 7N) . Notably, the number of immature Neus in the blood was highly correlated with the weight of the pancreas (Figure 7O ). In contrast, circulating mature Neus and Ly6C hi monocytes poorly correlated with the pancreas weight ( Figures S5F  and S5G ), which suggests that the presence of immature Neus in the blood might serve as a biomarker of disease progression. In summary, we have identified a strategy to distinguish immature from mature Neus in cancer, and our results reveal that increased numbers of circulating immature Neus are associated with increased tumor burden.
DISCUSSION
Although neutrophil heterogeneity is increasingly appreciated, their developmental path and functional properties from multipotent GMPs to mature neutrophils remains elusive (Silvestre-Roig et al., 2016) . Here, we have used the latest analytical approaches to establish a methodological framework to identify and provide an in-depth functional characterization of neutrophil subsets in their developmental pathway. Specifically, we identified a proliferative neutrophil precursor population, which we termed pre-neutrophils (preNeus), that gives rise to an intermediate population (immature Neus) in the BM before differentiating into mature neutrophils. Our sepsis and tumor models further revealed distinctive roles for preNeus and immature Neus, and the numbers of immature Neus correlated with tumor burden. More importantly, we also resolved the ongoing challenge of distinguishing neutrophil subsets during inflammation by identifying CD101 as a marker that segregates immature Neus from mature Neus in the circulation and tumor site. Our study hence fills a long-standing gap in the neutrophil development pathway by providing a conceptual framework that elucidates the functional characteristics of neutrophil subsets in both steady and inflammatory states. Neutrophil development has been characterized historically through a density-gradient separation technique, followed by their identification with Giemsa stain (Bjerregaard et al., 2003) . Although this approach delivers useful insights about neutrophil development and maturation, it lacks precision in delineating neutrophil heterogeneity at the single-cell resolution and does not allow downstream functional and molecular characterization. Here, we utilized mass-cytometry-based analytical approaches to identify differentially expressed surface markers on proliferating hematopoietic cells. These surface markers were then incorporated into subsequent flow-cytometric analysis in the Fucci-(S-G2-M) mouse, which led us to identify three BM neutrophil subsets, namely: preNeu, immature Neu, and mature Neu subsets. Of note, this approach was robust in both mice and humans and could also be applied to other leukocyte populations.
Although the commitment of multipotent precursors to cellrestricted precursors involves upregulating and silencing of lineage-specific and irrelevant genes, respectively (Fiedler and Brunner, 2012) , how precursors commit to the neutrophil lineage remains unclear. Our transcriptomic analysis of BM neutrophil subsets revealed TF silencing of Irf8, Gata1, and Gata2 and activation of Gfi1 and Cebpe in preNeus. Gfi1 is known to be critical for multipotent precursor commitment to the granulocytic lineage (Hock et al., 2003) . Thus, a specific upregulation of Gfi1 expression in preNeus further suggests that these cells are the first precursors committed to the neutrophil lineage. We confirmed the importance of C/EBPε in the development of preNeus to downstream neutrophil populations when we found that functionally mature neutrophils were absent in Cebpe À/À mice. We have also validated the developmental hierarchy of neutrophils to corroborate the notion that proliferative preNeus undergo an intermediate developmental phase as immature Neus before differentiating into functionally mature Neus. In alignment with this discovery, we believe that mapping of this trajectory in humans would provide further insights into the current established neutrophil development hierarchy.
Meeting the demand for functionally mature neutrophils during emergency granulopoiesis requires more myeloid precursors (Manz and Boettcher, 2014) . Consequently, our sepsis and tumor models demonstrate an expansion in the number of preNeus in both the spleen and BM during inflammation. Two possibilities might account for this phenomenon: an activation of extramedullary granulopoiesis in the spleen or deployment of BM preNeus to extramedullary sites in response to inflammatory stimuli. Our current findings rule out the latter possibility because preNeus were absent in the circulation (data not shown) and are poorly motile. The sessile nature of proliferative preNeus is in line with cancer biology's ''go or grow'' hypothesis, which postulates that cytoskeleton machineries are unable to cater to the needs of proliferation and migration simultaneously (Garay et al., 2013) . Therefore, the expansion in the number of splenic preNeus is most likely attributed to heightened extramedullary granulopoiesis through increased production of GM-CSF and IL-3 in the spleen microenvironment (Weber et al., 2015) .
In contrast to preNeus, immature Neus are non-proliferative but can enter the bloodstream during inflammatory conditions. Importantly, immature Neus could migrate toward the site of injury as efficiently as mature Neus. These data suggest that whereas preNeus are proliferative precursors that fine-tune the output of neutrophils, immature Neus might serve as a reservoir that can be deployed to sites of inflammation instead. The implications of this ''premature'' mobilization of immature Neus to the circulation and local sites of inflammation are currently unclear. Nevertheless, our tumor studies indicate a strong correlation between the numbers of circulating immature Neus and tumor burden, suggesting that their numbers could be used as a prognostic measurement of tumor burden. These findings corroborate recent observations that neutrophils with immature or aberrant nuclear morphology in tumor-bearing mice (Coffelt et al., 2015) have been negatively associated with disease outcome (Sagiv et al., 2015; Yang et al., 2011) . Our study highlights an important role for immature Neus during diseases and unlocks potential research topics on the relationship between immature Neus and granulocytic myeloid-derived suppressor cells (G-MDSCs).
In summary, our study provides a conceptual advancement in the understanding of neutrophil development by identifying specialized granulocytic populations that ensure supply during homeostasis and early response under stress. More importantly, our current model might also serve as a fundamental platform for the re-examination of granulopoiesis under physiological and disease states, as well as the basis for new therapeutic interventions for neutrophil-related diseases.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Human Blood, Bone Marrow, and Cord Blood Samples All samples were obtained in accordance with a favorable ethical opinion from SingHealth CIRB (2014/664/F) or A*STAR, the Singapore Immunology Network. Consent for bone marrow samples was sought from healthy donors who were already giving bone marrow for a different study or a medical cause. Cord blood units that do not meet clinical grade were obtained from the Singapore Cord Blood bank for research.
METHOD DETAILS Treatments
For 5-Fluorouracil (5-FU) myeloablative treatment, mice were injected once intraperitoneally with 150mg/kg 5-FU (Sigma-Aldrich) or PBS control. For G-CSF treatment, mice were injected once intraperitoneally with 1.5mg of G-CSF/anti-G-CSF antibody complex (G-CSFcx) as previously described (Rubinstein et al., 2013) . Briefly, G-CSFcx were generated by incubating G-CSF (Neupogen) and anti-G-CSF (BVD11-37G10; Southern-Biotech) at 1:5 cytokine to antibody ratio for 20 min at 37 C, and were next diluted at least 10-fold in PBS before injection.
Tissue Preparation and Data Analysis for Flow Cytometry and Cell Sorting
Blood was obtained via an incision in the submandibular region and was then lysed in red blood cell lysis buffer (eBioscience). For BM cells, mice femurs were flushed using a 23-gauge needle in PBS containing 2 mM EDTA and 2% fetal bovine serum (FBS) and passed through a 70-mm nylon mesh sieve. Spleens were harvested and homogenized into single-cell suspensions using 70-mm nylon mesh sieves and syringe plungers. Antibodies were purchased from BD, Biolegend, eBioscience or R&D. For the identification of mouse myeloid cells, cells were stained with fluorophore-conjugated anti-mouse antibodies against CCR2 (475301) . Flow cytometry acquisition was performed on a 5-laser BD LSR II (BD) using FACSDiva software, and data was subsequently analyzed with FlowJo software (Tree Star). Cell numbers were quantified with count beads (CountBright; Life Technologies) according to the manufacturer's instructions. Sorting of BM neutrophil subsets were performed using a BD ARIAII (BD) to achieve > 98% purity.
Mass Cytometry (CyTOF) Sample Preparation, Acquisition, and Analysis For mass cytometry analysis, purified antibodies were obtained from BD Biosciences, Biolegend, eBioscience, BioXCell, and conjugated using MAXPARÒ DN3 antibody labeling kits (Fluidigm) according to manufacturer's instructions. Mice were injected once intraperitoneally with 2mg IdU (Sigma-Aldrich). Mice were euthanized 2h later, femurs were harvested, flushed in PBS and passed through a 70-mm nylon mesh sieve. BM cells were plated in a 96-well round bottom plate at a density of 5 3 10 6 cells per well. For human BM, aspirates were incubated in RPMI containing 10% FCS and 50mM IdU for 1h at 37 C. Cells were stained for viability with 100 mL of 50 mM of cisplatin (Sigma-Aldrich) for 5 minutes at 4 C. Cells were then washed with staining buffer (4% FBS, 0.05% sodium azide, 2 mM EDTA in 1X PBS) and incubated with anti-CCR2-APC, anti-CD34-FITC, anti-CD115-PE and anti-Flt3-biotin (mouse panel) or CXCR4-biotin, CXCR2-FITC, CD101-APC (human panel) in 50 mL reaction volume for 90 minutes at 4 C. Red blood cells were lysed with 1X RBS lysis buffer (eBioscience) and cells were washed with staining buffer. Cells were stained with 50 mL of metal isotope-labeled surface antibodies (See Table S1 and S2) on ice. After 30 minutes, cells were washed twice with staining buffer, once with PBS, and then fixed in 2% paraformaldehyde (PFA) (Electron Microscopy Sciences) in PBS at 4 C overnight. The next day, cells were pelleted and re-suspended in 200 mL 1X permeabilization buffer (Biolegend) and allowed to stand for 5 minutes on ice. Cells were then washed once with PBS and incubated with cellular barcodes on ice for 30 minutes as previously described (Becher et al., 2014) . Subsequently, cells were washed once with perm buffer and in staining buffer for 10 minutes on ice. Cellular DNA was labeled at room temperature with 250nM iridium intercalator (Fluidigm) in 2% PFA/PBS. After 20 minutes, cells were washed twice with staining buffer.
Prior to acquisition, cells were washed twice with water before final re-suspension in water. Cells were pooled from all samples, enumerated, filtered and diluted to a final concentration of 0.6 3 10 6 cells/mL. Mass-tag barcoding was used so that all samples could be acquired simultaneously. EQ Four Element Calibration Beads (Fluidigm) were added to the pooled samples at a final concentration of 1% prior to acquisition. Samples were acquired on a CyTOF2 (Fluidigm) equipped with a Super Sampler fluidic system (Victorian Airship & Scientific Apparatus LLC) at an event rate of < 500 events per second. After mass cytometry acquisition, data were exported in flow-cytometry (FCS) format, normalized and events with parameters having zero values were randomized using a uniform distribution of values between minus-one and zero. Each sample containing a unique combination of two metal barcodes was de-convoluted by Boolean gating using FlowJo software (Tree Star). Subsequently, manual gating was done to exclude residual beads, debris and dead cells. BM CD45 + IdU + (proliferative cells) and CD45 + IdU -(non proliferative cells) were gated using Flowjo, and exported as a FCS file. Random subsampling without replacement was performed to select 90000 events. Dimensional reduction of the CyTOF data was performed selecting the markers listed in Table S1 by t-distributed stochastic neighbor embedding (t-SNE) using the Cytofkit R package van der Maaten and Hinton, 2008) . Clusters were generated using the FlowSOM implementation in Cytofkit. Median intensity values per cluster for each marker were calculated and exported to produce heatmaps using R. The identity of each cluster was inferred based on the expression of each individual marker.
Whole-Mount Tissue Preparation and Immunostaining
Freshly dissected femurs of 6-10 week old mice were fixed in 4% PFA in 1X PBS containing 30% sucrose for 3 hours at room temperature with gentle shaking. The bones were washed with 1X PBS for 3 times (30-minute interval). Femurs were next placed in decalcifying solution containing 10% Ethylenediamine tetra-acetic acid (EDTA) in PBS at pH = 7 for 2 days at 4 C. After 3 washes with 1X PBS of 30 minutes each, femurs were embedded in 4% agarose and sectioned using a vibratome (Leica VT1000S) at a thickness of 250mm. Femur sections were blocked and permeabilized in staining buffer containing 10% dimethyl sulphoxide (DMSO) and 2.5% goat and donkey serum overnight. Sections were stained for 3 days with rat anti-mouse S100A9 (2B10, Abcam) and rabbit polyclonal laminin 1+2 (ab7363, Abcam) in staining buffer. Sections were subsequently washed 3 times with 1X PBS (1-hour interval), and stained for 2 days with anti-rat AF555 IgG and anti-rabbit AF647 IgG (Life Technologies). Sections were washed 3 times in 1X PBS (1-hour interval), and placed in RapiClear 1.55 (Sunjin Lab) for at least 30 min for refractive index matching. Sections were finally mounted in RapiClear 1.55 between two coverslips and sealed with vacuum grease (Dow Corning).
Multi-Photon Image Acquisition of Femur Sections
Three-dimensional (3D) mosaic images of femur sections were acquired using a LaVision TriM Scope II microscope (LaVision BioTec), equipped with a water dipping objective (20x magnification, 1.0 NA, 2mm WD; XLUMPLFLN20xW, Olympus) and a Chameleon-pulsed infrared laser (titanium sapphire; Coherent). Acquisitions were performed two excitation wavelengths: 990nm and 800nm. 990nm excitation was used for the simultaneous imaging of Fucci-(S-G2-M) positive cells (l em = 505nm), second harmonic generation (SHG) (l em = 495nm), AF555 (l em = 565nm) and DsRed (l em = 580nm). Subsequently, imaging was performed at 800nm for the acquisition of AF647 (l em = 670nm). Filter used were: 494/41, 525/50, 565/40, 620/60 and 665/40 (Semrock). Dichroic mirrors used were a 495LP, 560LP, 620LP, 591sh (Semrock) and 640LP (Chroma Technology). Images were acquired with the following settings: 450mm 3 450mm, 517 3 517 pixels, 600Hz line scan with 2 frames of line averaging, using a 2mm z-step size with a depth of 250mm. The distal epiphysis was chosen as the area for imaging to maintain consistency between samples. 3D mosaic Z stack images were stitched together using FIJI is just ImageJ (FIJI), and subsequently rendered and analyzed using Imaris software (Bitplane). Spectral spillover between AF555 and DsRed was removed using Imaris with the channel arithmetic plugin. S100A9 + Fucci-(S-G2-M) + and S100A9 + Fucci-(S-G2-M) -cells were identified using the spots function tool in Imaris. Calculation of distance to the nearest vessels and CAR cell was performed using the Distance Transform MATLAB-based XTension built in Imaris. Raw statistics were then exported for further analysis in Prism (Graphpad).
Cytospin and Wright-Giemsa Staining
Sorted neutrophil subsets (1 3 10 5 cells each) were spun onto glass slides using Cytospin 4 Cytocentrifuge (Thermo scientific), dried for 20 minutes, fixed in methanol and stained with the Hema 3 manual staining system (Fisher Diagnostics) according to the manufacturer's protocol. Images were acquired with an Olympus BX43 equipped with a 100x oil immersion objected, and image brightness was adjusted with Photoshop (Adobe).
Transcriptomics GMP, preNeu, immature Neu, mature Neu and blood Neu from 3 different mice were sorted based on the gating strategy depicted in Figure 3A ). Total RNA isolation was subsequently performed using Arcturus PicoPure RNA Isolation kit according to the manufacturer's protocol. All mouse RNAs were analyzed on Perkin Elmer Labchip GX system for quality assessment with RIN > 7.7. cDNA libraries were prepared using 2ng of total RNA and 1mL of a 1:50000 dilution of ERCC RNA Spike in Controls (Ambion) using SMARTSeq v2 protocol (Picelli et al., 2014) , except for the following modifications: (1) use of 20 mM TSO; and (2) use of 250pg of cDNA with 1/5 reaction of Illumina Nextera XT kit. The length distribution of the cDNA libraries was monitored using DNA High Sensitivity Reagent kit on the Perkin Elmer Labchip. All 18 samples were subjected to an indexed PE sequencing run of 2 3 51 cycles on an Illumina HiSeq 2500 Rapid mode.
RNA-Seq data in the form of FASTQ files were subsequently mapped to the mouse genome build mm10 using the STAR alignment software. The mapped reads were then counted using featureCounts (part of Subread package) based on the GENCODE M7 annotations. The raw counts were then used for a differential gene expression analysis (DEG) using edgeR (R version 3.1.2) with FDR < 0.05 and log 2 FC > 2 to identify genes differentially regulated in neutrophil subsets to generate volcano plots. Count per million reads (CPM) values were calculated from raw counts using edgeR (R version 3.1.2). The CPM values were then log 2 -transformed in R (x -> log 2 (1+x)). For PCA, hierarchical clustering and correlation matrices, the gene expression matrix was first segregated using the top 20% variable genes (as measured by standard deviation across samples) and then those that were significantly associated with a cell population (FDR-corrected ANOVA, q-value < 0.05) resulting in 4820 DEGs. For hierarchical clustering, we used Euclidean distance and the Ward aggregation criterion and the pheatmap package to plot the results as a heatmap. The correlation matrix was computed using Pearson's correlation coefficients. Gene ontology (GO) enrichment (GO Biological Process 2015) of DEGs was done using Enrichr (Chen et al., 2013) .
Computational Inference of Developmental Path R package seriation 2 (Hahsler et al., 2008) was used to find a suitable linear order for GMP, preNeu, immature Neu, mature Neu and blood Neu. Six different seriation methods including TSP, R2E, ARSA, HC, GW and OLO. TSP, ARSA, GW and OLO produced identical and the best results in terms of shortest path length, minimal AR events and minimum Moore stress. Seriation analysis was done using log 2 CPM values of all detected genes.
In Vitro Cell Culture Sorted cells (3 3 10 4 for each neutrophil subset) were plated onto 96-well plates in triplicates and cultured at 37 C, 5% CO 2 in Iscove's Modified Dulbecco's Medium with 25mM HEPES and L-Glutamine (Chemtron) containing 10% (vol/vol) FBS, 1 mM sodium pyruvate, penicillin (100 U/ml) and streptomycin (100 ug/ml). Colony-formation assays were performed as described before (Hettinger et al., 2013) . Briefly, sorted cells (3 3 10 4 for each neutrophil subset) were cultured for in Iscove's modified Dulbecco's medium (Sigma) with the supplements mentioned above, 1% (wt/vol) methylcellulose (MethoCult M3134, Stem Cell Technologies) and a combination of cytokines (50ng/ml SCF, 20ng/ml LIF, 10ng/ml IL-3, 20ng/ml IL-6). Representative colony images were collected with an Olympus IX-81 microscope (Olympus). Image brightness was adjusted with Photoshop.
BrdU Pulsing Assays
For in vivo assays, mice were injected intraperitoneally with 2mg 5-bromo-2 0 -deoxyuridine (BrdU; Sigma-Aldrich) at indicated time points. To detect BrdU incorporation into neutrophil subsets, cells were stained with a fixable vitality dye (Zombie UV fixable viability kit; Biolegend), surface-stained, fixed, permeabilized, and subjected to intracellular staining with FITC-conjugated anti-BrdU antibody, according to the manufacturer's protocol (BrdU Flow kit; BD) before analysis by flow cytometry.
Adoptive Cell Transfer
Sorted Lyz2 gfp/+ preNeu (2 3 10 5 cells) were transferred intra-BM into wild-type recipients as described previously . In brief, recipient mice were anesthetized with ketamine (150mg/kg) / xylazine (10 mg/kg), and had their right leg shaved to expose the kneecap. Sorted preNeu were resuspended in 1X PBS at a concentration of 2 3 10 4 cells/mL, and a volume of 10mL was administered into the tibia through the kneecap using a 29-gauge insulin needle. At 24 and 48 hours after cell transfer, tibias were collected, stained and analyzed by flow cytometry.
Laser-Induced Sterile Injury Model
Neutrophil subsets were sorted from either Lyz2 gfp/+ (GFP) or Rosa26 mT/mG (tdTomato) transgenic mice as indicated, and were mixed in a 1:1 ratio (each 2.5 3 10 5 cells). Cells were resuspended at a concentration of 0.1 3 10 5 cells/mL. A 2.5mL volume of neutrophil suspension was injected intradermally in the ear with a Hamilton syringe (33-gauge, 62RN). B6(Cg)-Tyrc -2J /J (B6 albino) mice were used as recipient mice in all experiments. After two to three hours, mice were prepared for skin multiphoton imaging and laser focal injury was then performed as described previously (Li et al., 2012) . Briefly, anesthetized mice were set up onto a custom ear imaging stage platform to stabilize the ear for intravital imaging. To induce a sterile injury, a chosen area (75 mm 2 ) close to the injection site was briefly exposed to a focused laser pulse (850nm) for $5 s. For image acquisition, an excitation wavelength of 990 nm was used to collect GFP (l em = 510nm), tdTomato (l em = 580nm) and second harmonic generation (SHG) (l em = 495nm) simultaneously. Filters used were 494/41, 510/20 and 579/34 (Semrock). Dichroic mirrors used were a 495 LP (Semrock), 560 LP (Semrock) and 640 LP (Chroma Technology). A scan-field dimension of 500 mm 3 500 mm, with a Z-step size of 4 mm was used to acquire the 40-50 mm stacks, taken at every half-minute intervals for 1 hour. Mice body temperatures were kept at 37 C with a heating pad and mice ears were separately warmed at 35 C during imaging. After acquisition, data correction and analysis were conducted using Imaris (Bitplane). Where necessary, FIJI is just ImageJ (FIJI) was used to correct for drifts that occurred during acquisition. Cell tracking was done semi-automatically in Imaris using the ''spots'' function and the ''auto-regressive motion'' algorithm. Reconstructed images and videos were finally generated using Imaris.
Oxidative Burst Assay Sorted neutrophils (5 3 10 5 for each cell subset) were incubated with 2.5mg/mL Dihydrorhodamine 123 (DHR) (ThermoFisher) in RPMI, and subjected to 50nM Phorbol 12-Myristate 13-Actetate (PMA) (Sigma-Aldrich) for 20 min at 37 C. Cells were subsequently washed with PBS and the fluorescence intensities of each subset were measured by flow cytometry.
Phagocytosis Assay In Vitro DH5a Escherichia coli (E. coli) expressing GFP (Chua and Wong, 2013) were grown in Lysogeny Broth (LB) medium overnight at 37 C to an Optical Density (OD) at 600 nm of 1.5-1.8, at which point the bacteria were diluted and grown for 1-2 hours to an OD600 of $0.5, and were finally washed twice with PBS. Sorted neutrophils (1 3 10 5 for each cell subset) were incubated with bacteria in a ratio of 1:100 for 2 hours at 37 C. After incubation, the cells were washed with PBS, fixed with 2% PFA and analyzed by flow cytometry.
Reverse Passive Arthus (RPA) Reaction RPA was conducted as described before (Li et al., 2016) . Briefly, mice were intravenously injected with Evans blue dye (SigmaAldrich) at 8 mL/g bodyweight, 10mg/ml in saline). RPA reaction is initiated by intradermal injection of 1.5 mL of 10mg/mL anti-BSA (Sigma-Aldrich), followed by intraperitoneal injection of 200 mL of 5mg/ml BSA (Sigma-Aldrich). For quantification of neutrophil numbers, mouse ears were subjected to tissue homogenization and enzymatic digestion as described (Li et al., 2016) , followed by flow-cytometric analysis. For quantification of vascular leakage, readings were obtained through digital photographic analysis methods.
CLP-Induced Mid-Grade Sepsis
Cecal ligation and puncture was performed as described previously (Rittirsch et al., 2009) . Briefly, the peritoneal cavity was exposed under ketamine/xylazine anesthesia and the cecum was exteriorized. 50% of the cecum was ligated distal of the ileo-cecal valve using a non-absorbable 7-0 suture. A 26-gauge needle was used to perforate the distal end of the cecum, and a small drop of feces was extruded through the puncture before being relocated into the peritoneal cavity. The peritoneum was closed and mice were subsequently treated with saline and Buprenorphine (5-20 mg/kg) by subcutaneous injection. For sham-operated controls, the peritoneum was exposed and the cecum was exteriorized before closing the peritoneum as mentioned above. Mice were euthanized and harvested 24 hours or 2 weeks after the surgery where indicated. For bacterial CFU measurements, blood and peritoneal fluid were collected after 24 hours and cultured overnight at 37 C on blood-agar base plates (Trypticase Soy Agar II; Fisher scientific) and LB agar plates respectively. ; LsL-Trp53 R172H/+ (termed KPC) mice as previously described (Zambirinis et al., 2015) . Briefly, mice were anesthetized with ketamine/xylazine, and had their abdomen shaved and swabbed with antiseptics. A 5mm vertical incision was made in the skin and abdominal layer at a point 1cm down from the xiphoid process of the sternum, and 1cm to the right of the midline. The pancreas was exposed, 1 3 10 5 tumor cells were resuspended in 1X PBS and mixed with matrigel (BD) in a 1:1 ratio, and were injected as a volume of 50mL into the body of the pancreas to form a visible bolus using a 29-gauge insulin needle. The pancreas was then returned to the abdominal cavity. The abdominal layer was closed with absorbable 5/0 sutures, while the skin was closed with non-absorbable 5/0 sutures. Superglue was applied over the sutures to ensure that they do not come undone after surgery. Mice were resuscitated with saline and were subcutaneously administered Buprenophrine (10mg/kg) and Enrofloxacin (Baytril, 1.5mg/kg) for the 2 days following surgery. Mice were euthanized at day 27-30 following surgery and tumor weights were recorded.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were done using Prism software (Graphpad). Student's t test or one-way analysis of variance (ANOVA) with Bonferroni correction were performed. For correlation analysis, linear regression was used to generate the best-fit line for graphical representation, and Pearson's correlation test was performed to generate p values. P values < 0.05 were considered as statistically significant.
